0001127602-24-004982.txt : 20240214 0001127602-24-004982.hdr.sgml : 20240214 20240214142330 ACCESSION NUMBER: 0001127602-24-004982 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desjarlais John R CENTRAL INDEX KEY: 0001591313 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 24636081 MAIL ADDRESS: STREET 1: C/O XENCOR, INC. STREET 2: 111 WEST LEMON AVENUE CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-13 0001326732 Xencor Inc XNCR 0001591313 Desjarlais John R C/O XENCOR, INC. 465 N HALSTEAD STREET, SUITE 200 PASADENA CA 91107 1 SR. VICE PRESIDENT & CSO 0 Common Stock 2024-02-13 4 M 0 68057 11.05 A 215783 D Common Stock 2024-02-13 4 S 0 54108 19.3824 D 161675 D Stock Option (Right to Buy) 11.05 2024-02-13 4 M 0 68057 0 D 2024-02-20 Common Stock 68057 11943 D This transaction is pursuant to a 10b5-1 plan. Underlying option due to expire in February 2024. Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise. 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. /s/ Celia E. Eckert, Attorney-in-Fact 2024-02-14